Personal information

Emails & domains

Verified email addresses

Verified email domains

Websites & social links

Personal website at University of Valencia
Website of Hepatology and Liver Trasplant Unit at IISLAFE

Other IDs

Scopus Author ID: 54682179100

Keywords

metabolomics, hepatology, liver diseases, toxicity, lipidomics

Countries

Spain, Denmark, Switzerland

Biography

Marta Moreno Torres holds a Bachelor's degree in Biotechnology at the Polytechnic University of Valencia (UPV), with a research stay at Technische Universität München (TUM) in Munich, Germany. Marta pursued a Master's degree in Biomedical Biotechnology at UPV, with research stays at prestigious institutions such as the Institute of Cellular and Molecular Biology of Plants (IBMCP, UPV-CSIC) and the National University of Ireland (NUIG) in Galway, Ireland.
Marta embarked on an international Ph.D. program at the Université de Fribourg (UniFr) in Fribourg, Switzerland. Afterwards, she obtained a highly competitive 2-year postdoctoral fellowship from the Danish Diabetes Academy. She relocated to Syddansk Universitet (SDU) in Odense, Denmark.
Subsequently, Marta returned to Spain to join the Health Research Institute Hospital La Fe (IISLAFE) in Valencia. There, she assumed a pivotal role with a Juan de la Cierva Incorporación fellowship, specializing on liquid chromatography, mass spectrometry and data analysis from human samples within a hospital environment. Her work aimed to translate her research findings into practical clinical applications within the field of hepatology.
Presently, she holds the prestigious Ramón y Cajal fellowship at the Department of Biochemistry and Molecular Biology within the Faculty of Medicine at the University of Valencia (UV), Spain. Her research is based on a wide set of techniques, including biochemistry, molecular and cellular biology, and cutting-edge mass spectrometry 'omics' technologies.

Activities

Collapse all

Employment (7)

Universidad de Valencia: Valencia, ES

2023-01-01 to 2027-12-31 | Ramón y Cajal Researcher (Biochemistry and Molecular Biology Department)
Employment
Source: Self-asserted source
Marta Moreno Torres

Instituto de Investigación Sanitaria La Fe: Valencia, Valencia, ES

2020-07-01 to 2022-12-31 | Juan de la Cierva Incorporación Researcher (Experimental Hepatology and Liver Transplant Unit)
Employment
Source: Self-asserted source
Marta Moreno Torres

Instituto de Investigación Sanitaria La Fe: Valencia, Valencia, ES

2019-08-26 to 2020-06-30 | Post-doctoral researcher (Experimental Hepatology and Liver Transplant Unit)
Employment
Source: Self-asserted source
Marta Moreno Torres

University of Southern Denmark: Odense, Denmark, DK

2016-10-01 to 2019-05-31 | Post-doctoral researcher (Biochemistry and Molecular Biology)
Employment
Source: Self-asserted source
Marta Moreno Torres

Université de Fribourg: Fribourg, Fribourg, CH

2016-06-29 to 2016-09-30 | Post-doctoral researcher (Biochemistry)
Employment
Source: Self-asserted source
Marta Moreno Torres

Université de Fribourg: Fribourg, Fribourg, CH

2012-02-01 to 2016-06-28 | PhD student (Biochemistry )
Employment
Source: Self-asserted source
Marta Moreno Torres

Instituto de Biología Molecular y Celular de Plantas: Valencia, Valenciana, ES

2010-10-01 to 2012-01-31 | Master Student (Biotechnology)
Employment
Source: Self-asserted source
Marta Moreno Torres

Education and qualifications (3)

Université de Fribourg: Fribourg, Fribourg, ES

2012-02-01 to 2016-06-28 | PhD in Biochemistry (Biochemistry)
Education
Source: Self-asserted source
Marta Moreno Torres

Universidad Politécnica de Valencia: Valencia, Valencia, ES

2012-01-09 | Máster en Biotecnología Biomédica
Education
Source: Self-asserted source
Marta Moreno Torres

Universidad Politécnica de Valencia: Valencia, Valencia, ES

2010-06-24 | Licenciada en Biotecnología
Education
Source: Self-asserted source
Marta Moreno Torres

Professional activities (7)

Ayudas Predoctorales de la Asociación Española Contra el Cáncer: Valencia, ES

2023-01-01 to present | Evaluator
Service
Source: Self-asserted source
Marta Moreno Torres

Agencia Estatal de Investigación: Madrid, Comunidad de Madrid, ES

2021-05-01 to present | Member of the bank of experts
Service
Source: Self-asserted source
Marta Moreno Torres

Narodowe Centrum Nauki: KRAKOW, PL

2021 to present | Project reviewer
Service
Source: Self-asserted source
Marta Moreno Torres

Metabolomics Society: Valencia, Valencia, ES

2020 to present
Membership
Source: Self-asserted source
Marta Moreno Torres

Nordic Metabolomics Society: Odense, DK

2019 to present | Post-doctoral researcher
Membership
Source: Self-asserted source
Marta Moreno Torres

Metabolomics Society: Valencia, ES

2022-06-23 | Early-Career Researcher Travel Award for Metabolomics 2022
Distinction
Source: Self-asserted source
Marta Moreno Torres

Universidad Politécnica de Valencia: Valencia, Valencia, ES

2010-09-01 to 2011-09-01 | Member of the academic committee (Master in Biomedical Biotechnology)
Service
Source: Self-asserted source
Marta Moreno Torres

Funding (20)

Exposoma, microbioma y comorbilidades prevalentes como factores de susceptibilidad en la lesión hepática idiosincrática inducida por medicamentos

2025-01 to 2027-12 | Grant
Instituto de Salud Carlos III (Valencia, ES)
Source: Self-asserted source
Marta Moreno Torres

METBIOFAT: Identificación de biomarcadores no invasivos para el diagnóstico y estratificación de hígado graso mediante estrategia metabolómica

2024-04 to 2025-04 | Grant
Universitat de València / INCLIVA (Valencia, ES)
URL: https://vlc-bioclinic.es/
Source: Self-asserted source
Marta Moreno Torres

Ramón y Cajal 2021

2023-01 to 2027-12 | Contract
Ministerio de Ciencia e Innovación (Valencia, ES)
GRANT_NUMBER:

RYC2021-031346-I
Source: Self-asserted source
Marta Moreno Torres

Biomarcadores metabolómicos y otros factores predictivos del síndrome de obstrucción sinusoidal (SOS) en el trasplante de progenitores hematopoyéticos

2023-01 to 2025-12 | Grant
Instituto de Salud Carlos III (Madrid, ES)
Source: Self-asserted source
Marta Moreno Torres

Esteatosis hepática inducida por valproato en pacientes epilépticos pediátricos: Bases moleculares e identificación de biomarcadores metabolómicos de la enfermedad hepática y prueba de concepto clínico de un posible tratamiento coadyuvante con carnitina.

2023-01 to 2024-12 | Grant
Conselleria d' Educació, Universitats i Ocupació (Generalitat Valenciana) (Valencia, ES)
Source: Self-asserted source
Marta Moreno Torres

Identificación de biomarcadores de gravedad no invasivos en enfermedad por hígado graso no alcohólico (NAFLD)y su validación en suero, como biomarcadores predictivos: estudio metabolómico y miRNómico en pacientes sometidos a cirugía bariátrica

2022-05 to present | Grant
Sociedad Española de Cirugía de la Obesidad (Madrid, ES)
Source: Self-asserted source
Marta Moreno Torres

ONTOX PROJECT: Ontology-driven and artificial intelligence-based repeated dose toxicity testing of chemicals for next generation risk assessment

2021 to 2026-04 | Grant
European Union´s Horizon 2020 (Brussels, BE)
URL: https://ontox-project.eu/
Source: Self-asserted source
Marta Moreno Torres

Factores de susceptibilidad y biomarcadores no invasivos para la esteatosis hepática inducida por valproato en pacientes con epilepsia

2020-09 to 2023-09 | Grant
Instituto de Salud Carlos III (Valencia, ES)
Part of GRANT_NUMBER:

PI20/00690
Source: Self-asserted source
Marta Moreno Torres

Juan de la Cierva Incorporación

2020-07 to 2023-11 | Salary award
Ministerio de Ciencia e Innovación (Valencia, ES)
GRANT_NUMBER:

IJC2018-046209-I
Source: Self-asserted source
Marta Moreno Torres

Metabolomics approach to uncover the role of sphingolipids in metabolic diseases

2016-10 to 2018-11 | Grant
Danish Diabetes Academy (Odense, DK)
Source: Self-asserted source
Marta Moreno Torres

A metabolomics approach to uncover the role of sphingolipids in metabolic diseases

2016-10 to 2018-09 | Grant
Danish Diabetes Academy (Odense, DK)
Source: Self-asserted source
Marta Moreno Torres

Coordination of growth and cell division by nutrient signaling pathways in yeast

2016-06 to present | Grant
Novartis Foundation (Basel, CH)
Source: Self-asserted source
Marta Moreno Torres

An integrated european 'flagship' program driving mechanism-based toxicity testing and risk assessment for the 21st century Degree of contribution: Researcher

2016-01 to 2021-12 | Grant
Horizon 2020 Framework Programme (Valencia, ES)
Part of GRANT_NUMBER:

681002
Source: Self-asserted source
Marta Moreno Torres

Nutrient signal transduction and control of quiescence in yeast

2013-08 to 2016-07 | Grant
Swiss National Science Foundation (Bern, CH)
Part of GRANT_NUMBER:

146216
Source: Self-asserted source
Marta Moreno Torres

Coordination of growth and cell division by nutrient signaling pathways in yeast

2012-05 to present | Grant
Novartis Foundation (Fribourg, CH)
Source: Self-asserted source
Marta Moreno Torres

Collaboration Fellowship at IBMCP at UPV

2010-09 to present | Grant
Universidad Politécnica de Valencia (Valencia, ES)
Source: Self-asserted source
Marta Moreno Torres

Materiales para la liberación controlada en sistemas celulares

2009-12 to 2010-12 | Grant
Universidad Politécnica de Valencia (Valencia, ES)
Source: Self-asserted source
Marta Moreno Torres

Control traduccional y supervivencia celular en respuesta al estrés: Identificación de nuevos efectores regulados por la eIF2 quinasa Gcn2

2008-09 to 2009-09 | Grant
Universidad Politécnica de Valencia (Valencia, ES)
Source: Self-asserted source
Marta Moreno Torres

A Novel UPLC-MS Metabolomic Analyses-Based Strategy to Monitor the Course and Extent of iPSC Differentiation to Hepatocytes

Award
Metabolomics Society (Valencia, ES)
URL: https://www.metabolomics2022.org/awards
Source: Self-asserted source
Marta Moreno Torres

Metabolomics as an innovative tool for investigating and anticipating the hepatic toxicity caused by drugs in humans

Award
Ajuntament d' Algemesí (Algemesí, ES)
Source: Self-asserted source
Marta Moreno Torres

Works (30)

Improving insights from metabolomic functional analysis combining multivariate tools

Analytica Chimica Acta
2024-09 | Journal article
DOI: 10.1016/j.aca.2024.343062
Contributors: Julia Kuligowski; Marta Moreno-Torres; Guillermo Quintás
Source: check_circle
Crossref

Novel clinical phenotypes, drug categorization, and outcome prediction in drug-induced cholestasis: Analysis of a database of 432 patients developed by literature review and machine learning support

Biomedicine & Pharmacotherapy
2024-05 | Journal article
DOI: 10.1016/j.biopha.2024.116530
Contributors: Marta Moreno-Torres; Ernesto López-Pascual; Anna Rapisarda; Guillermo Quintás; Annika Drees; Inger-Lise Steffensen; Thomas Luechtefeld; Eva Serrano-Candelas; Marina Garcia de Lomana; Domenico Gadaleta et al.
Source: check_circle
Crossref

Assessing ATR-FTIR spectroscopy for steatosis quantification in liver biopsies in a long-duration cross-sectional study

Microchemical Journal
2024-03 | Journal article
DOI: 10.1016/j.microc.2024.110135
Contributors: Iván Rienda; Marta Moreno-Torres; Erika Moro; Judith Pérez-Rojas; Eugenia Pareja; Álvaro Pérez-Rubio; Nuria Peris; Jose Ángel Díez Ares; Ramón Trullenque; Ramiro Jover et al.
Source: check_circle
Crossref

Exploring Individual Variability in Drug-Induced Liver Injury (DILI) Responses through Metabolomic Analysis

International Journal of Molecular Sciences
2024-03-05 | Journal article
DOI: 10.3390/ijms25053003
Contributors: Marta Moreno-Torres; Guillermo Quintás; Teresa Martínez-Sena; Ramiro Jover; José V. Castell
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Cluster-Partial Least Squares (c-PLS) regression analysis: Application to miRNA and metabolomic data

Analytica Chimica Acta
2024-01 | Journal article
DOI: 10.1016/j.aca.2023.342052
Contributors: Julia Kuligowski; Álvaro Pérez-Rubio; Marta Moreno-Torres; Polina Soluyanova; Judith Pérez-Rojas; Iván Rienda; David Pérez-Guaita; Eugenia Pareja; Ramón Trullenque-Juan; José V. Castell et al.
Source: check_circle
Crossref

Enhancing the accuracy of Mid-Infrared Spectroscopy Liver Steatosis quantification using Digital Image Analysis as Reference

The Analyst
2023 | Journal article
DOI: 10.1039/d3an00324h
Part of ISSN: 0003-2654
Part of ISSN: 1364-5528
Contributors: Iván Rienda; Isabel Ten-Doménech; Erika Moro; Marta Moreno-Torres; Judith Pérez-Rojas; Eugenia Pareja; Alvaro Perez-Rubio; Ramon Trullenque-Juan; Ramiro Jover; Bernhard Lendl et al.
Source: Self-asserted source
Marta Moreno Torres

OS02-01: Novel clinical phenotypes and chemical classifications in drug-induced cholestasis: analysis of a database of 390 patients developed by collaborative literature review and machine learning support

Toxicology Letters
2023-09 | Journal article
DOI: 10.1016/s0378-4274(23)00421-6
Part of ISSN: 0378-4274
Contributors: M. Moreno Torres; E. Lopez Pascual; A.S. Rapisarda; G. López; T. Bozada Jr; J. Jiang; J. van Ertvelde; I.-L. Steffensen; B. Lindeman; T. Luechtefeld et al.
Source: Self-asserted source
Marta Moreno Torres

P16-55: Using Metabolomics to Uncover Ontogeny of Drug-Induced Hepatotoxicity and Underlying AOP Mechanisms

Toxicology Letters
2023-09 | Journal article
DOI: 10.1016/s0378-4274(23)00744-0
Part of ISSN: 0378-4274
Contributors: T. Martinez-Sena; E. Moro; M. Moreno Torres; G. Quintas; J. Hengstler; R. Jover; J. V. Castell Ripoll
Source: Self-asserted source
Marta Moreno Torres

Progress and challenges of mid-infrared spectroscopy for liver characterization focusing on steatosis, fibrosis and cancer

Applied Spectroscopy Reviews
2023-06-05 | Journal article
DOI: 10.1080/05704928.2023.2215858
Part of ISSN: 0570-4928
Part of ISSN: 1520-569X
Contributors: Isabel Ten-Doménech; Ivan Rienda; Judith Pérez-Rojas; Eugenia Pareja; Marta Moreno-Torres; Jose V. Castell; Bernhard Lendl; Andreas Schwaighofer; David Pérez-Guaita; Julia Kuligowski et al.
Source: Self-asserted source
Marta Moreno Torres

The assessment of the potential hepatotoxicity of new drugs by in vitro metabolomics

Frontiers in Pharmacology
2023-05-05 | Journal article
DOI: 10.3389/fphar.2023.1155271
Part of ISSN: 1663-9812
Contributors: Guillermo Quintás; José V. Castell; Marta Moreno-Torres
Source: Self-asserted source
Marta Moreno Torres

Metabolomics-based strategy to assess drug hepatotoxicity and uncover the mechanisms of hepatotoxicity involved

Archives of Toxicology
2023-04-06 | Journal article
DOI: 10.1007/s00204-023-03474-8
Part of ISSN: 0340-5761
Part of ISSN: 1432-0738
Contributors: Teresa Martínez-Sena; Erika Moro; Marta Moreno-Torres; Guillermo Quintás; Jan Hengstler; Jose V. Castell
Source: Self-asserted source
Marta Moreno Torres

Metabolomic Diversity of Human Milk Cells over the Course of Lactation—A Preliminary Study

Nutrients
2023-02-22 | Journal article
DOI: 10.3390/nu15051100
Contributors: Isabel Ten-Doménech; Mari Merce Cascant-Vilaplana; Víctor Navarro-Esteve; Birgit Felderer; Alba Moreno-Giménez; Iván Rienda; María Gormaz; Marta Moreno-Torres; David Pérez-Guaita; Guillermo Quintás et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Analysis of longitudinal metabolomic data using multivariate curve resolution-alternating least squares and pathway analysis

Chemometrics and Intelligent Laboratory Systems
2023-01 | Journal article
DOI: 10.1016/j.chemolab.2022.104720
Part of ISSN: 0169-7439
Contributors: Isabel Ten-Doménech; Marta Moreno-Torres; Juan Daniel Sanjuan-Herráez; David Pérez-Guaita; GUILLERMO QUINTÁS; Julia Kuligowski
Source: Self-asserted source
Marta Moreno Torres

SOC-V-11 New serum miRNA biomarkers to predict liver steatosis by valproic acid in paediatric epileptic patients

Toxicology Letters
2022-09 | Journal article
DOI: 10.1016/j.toxlet.2022.07.200
Part of ISSN: 0378-4274
Contributors: R. Jover; P. Soluyanova; E. Moro-Castaño; M. Moreno-Torres; A.V. Marco-Hernández; M. Tomas-Vila; J.V. Castell
Source: Self-asserted source
Marta Moreno Torres

Valproate and Short-Chain Fatty Acids Activate Transcription of the Human Vitamin D Receptor Gene through a Proximal GC-Rich DNA Region Containing Two Putative Sp1 Binding Sites

Nutrients
2022-06-28 | Journal article | Author
DOI: 10.3390/nu14132673
Part of ISSN: 2072-6643
Contributors: Marta Moreno Torres; Carla Guzmán; Petar Petrov; RAMIRO JOVER
Source: Self-asserted source
Marta Moreno Torres
grade
Preferred source (of 3)‎

The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment

Metabolites
2022-06-19 | Journal article
DOI: 10.3390/metabo12060564
Contributors: Marta Moreno-Torres; Guillermo Quintás; José V. Castell
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

A Novel UPLC-MS Metabolomic Analysis-Based Strategy to Monitor the Course and Extent of iPSC Differentiation to Hepatocytes

Journal of Proteome Research
2022-03-04 | Journal article | Author
DOI: 10.1021/acs.jproteome.1c00779
Part of ISSN: 1535-3893
Part of ISSN: 1535-3907
Contributors: Marta Moreno Torres; Manoj Kumar; Guillem García-Llorens; Guillermo Quintás; Tine Tricot; Ruben Boon; Laia Tolosa; Burak Toprakhisar; Francois Chesnais; Catherine Verfaillie et al.
Source: Self-asserted source
Marta Moreno Torres
grade
Preferred source (of 2)‎

The effect of Holder pasteurization on the lipid and metabolite composition of human milk.

Food chemistry
2022-02-26 | Journal article
DOI: 10.1016/j.foodchem.2022.132581
PMID: 35257998
Source: Self-asserted source
Marta Moreno Torres

Extracting consistent biological information from functional results of metabolomic pathway analysis using the Mantel's test

Analytica Chimica Acta
2021-12 | Journal article
DOI: 10.1016/j.aca.2021.339173
Contributors: Isabel Ten-Doménech; Marta Moreno-Torres; José Vicente Castell; Guillermo Quintás; Julia Kuligowski
Source: check_circle
Crossref

Factors that influence the quality of metabolomics data in in vitro cell toxicity studies: a systematic survey.

Scientific reports
2021-11-11 | Journal article
DOI: 10.1038/s41598-021-01652-1
PMID: 34764412
PMC: PMC8586040
Source: Self-asserted source
Marta Moreno Torres

Toward Rapid Screening of Liver Grafts at the Operating Room Using Mid-infrared Spectroscopy.

Analytical chemistry
2020-10-21 | Journal article
DOI: 10.1021/acs.analchem.0c02735
PMID: 33084322
Source: Self-asserted source
Marta Moreno Torres

Analysis of the Association between Fatigue and the Plasma Lipidomic Profile of Inflammatory Bowel Disease Patients.

Journal of proteome research
2020-10-06 | Journal article
DOI: 10.1021/acs.jproteome.0c00462
PMID: 32969224
Source: Self-asserted source
Marta Moreno Torres

Phosphoproteomic Analysis across the Yeast Life Cycle Reveals Control of Fatty Acyl Chain Length by Phosphorylation of the Fatty Acid Synthase Complex

Cell Reports
2020-08 | Journal article
DOI: 10.1016/j.celrep.2020.108024
Part of ISSN: 2211-1247
Contributors: Fernando Martínez-Montañés; Albert Casanovas; Richard R. Sprenger; Magdalena Topolska; David L. Marshall; Marta Moreno-Torres; Berwyck L.J. Poad; Stephen J. Blanksby; Martin Hermansson; Ole N. Jensen et al.
Source: Self-asserted source
Marta Moreno Torres

Comparing Targeted vs. Untargeted MS2 Data-Dependent Acquisition for Peak Annotation in LC–MS Metabolomics

Metabolites
2020-03-26 | Journal article
DOI: 10.3390/metabo10040126
Part of ISSN: 2218-1989
Contributors: Isabel Ten-Doménech; Teresa Martinez-Sena; Marta Moreno-Torres; Juan Daniel Sanjuan-Herráez; Jose V. Castell; ANNA PARRA LLORCA; Vento M; Guillermo Quintás; Julia Kuligowski
Source: Self-asserted source
Marta Moreno Torres

LC-MS analyses of lipid species in skeletal muscle cells and tissue

Methods in Molecular Biology
2019 | Book chapter
DOI: 10.1007/978-1-4939-8897-6_12
EID:

2-s2.0-85055615683
Contributors: Moreno-Torres, M.; Havelund, J.F.; Faergeman, N.J.
Source: Self-asserted source
Marta Moreno Torres via Scopus - Elsevier

Cardiolipin Synthesis in Brown and Beige Fat Mitochondria Is Essential for Systemic Energy Homeostasis

Cell Metabolism
2018 | Journal article
DOI: 10.1016/j.cmet.2018.05.003
EID:

2-s2.0-85047218679
Contributors: Sustarsic, E.G.; Ma, T.; Lynes, M.D.; Larsen, M.; Karavaeva, I.; Havelund, J.F.; Nielsen, C.H.; Jedrychowski, M.P.; Moreno-Torres, M.; Lundh, M. et al.
Source: Self-asserted source
Marta Moreno Torres via Scopus - Elsevier

TORC1 coordinates the conversion of Sic1 from a target to an inhibitor of cyclin-CDK-Cks1

Cell Discovery
2017 | Journal article
DOI: 10.1038/celldisc.2017.12
EID:

2-s2.0-85022208846
Contributors: Moreno-Torres, M.; Jaquenoud, M.; Péli-Gulli, M.-P.; Nicastro, R.; De Virgilio, C.
Source: Self-asserted source
Marta Moreno Torres via Scopus - Elsevier

TORC1 controls G 1 -S cell cycle transition in yeast via Mpk1 and the greatwall kinase pathway

Nature Communications
2015 | Journal article
DOI: 10.1038/ncomms9256
EID:

2-s2.0-84941588331
Contributors: Moreno-Torres, M.; Jaquenoud, M.; De Virgilio, C.
Source: Self-asserted source
Marta Moreno Torres via Scopus - Elsevier

Targeted cargo delivery in senescent cells using capped mesoporous silica nanoparticles

Angewandte Chemie - International Edition
2012 | Journal article
DOI: 10.1002/anie.201204663
EID:

2-s2.0-84867507072
Contributors: Agostini, A.; Mondragõn, L.; Bernardos, A.; Martínez-Máñez, R.; Dolores Marcos, M.; Sancenõn, F.; Soto, J.; Costero, A.; Manguan-García, C.; Perona, R. et al.
Source: Self-asserted source
Marta Moreno Torres via Scopus - Elsevier

Between Scylla and Charibdis: EIF2α kinases as targets for cancer chemotherapy

Clinical and Translational Oncology
2011 | Journal article
DOI: 10.1007/s12094-011-0680-3
EID:

2-s2.0-82255174098
Contributors: Moreno-Torres, M.; Murguía, J.R.
Source: Self-asserted source
Marta Moreno Torres via Scopus - Elsevier

Peer review (13 reviews for 7 publications/grants)

Review activity for Analyst. (2)
Review activity for Drug design, development and therapy (1)
Review activity for International journal of molecular sciences. (5)
Review activity for Medicina. (1)
Review activity for Metabolites. (2)
Review activity for Toxicology (1)
Review activity for Toxics. (1)
How many people are using ORCID?